Trial Profile
Study of eculizumab for the treatment of chronic antibody-mediated injury in kidney transplant recipients
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 20 Dec 2015
Price :
$35
*
At a glance
- Drugs Eculizumab (Primary)
- Indications Renal transplant rejection
- Focus Therapeutic Use
- 20 Dec 2015 New trial record